Part of UT Health San Antonio

Part of UT Health San Antonio

You are here

2c3_366_13070105_1580036173_6.jpg

Contact

210-567-4700

bansals3@uthscsa.edu

Departments & Divisions

Research Areas

Cardiovascular Diabetes & Kidney Health

Shweta Bansal, MBBS, MD, FASN

Professor of Medicine

Dr. Bansal joined the Division of Nephrology at UT Health San Antonio in 2010 after obtaining medical degree from SMS Medical College, India and Nephrology Fellowship from the University of Colorado, Denver.  Currently, she is a clinical Professor of Medicine, and Director of Home Dialysis Program and CTSA-Hub Liaison Team. Dr. Bansal adores the pathophysiological role kidneys play in health and diseases and is passionate about teaching this role to students, patients and colleagues. She has been highly recognized for her outstanding teaching abilities and has won several teaching awards.  For patient care, Dr. Bansal strongly believe that empowerment of patients through improving health literacy is the most important step to achieve the best outcomes. I received the 2023 UT Health Presidential Award for Clinical Excellence.

Dr. Bansal established the home dialysis program using a team approach in 2011. By providing opportunities to learn and practice home dialysis to the fellows, she has been addressing the issue of shortage of home dialysis competent nephrologists, one of the main barriers for low uptake of this modality. Her participation as the councilor of ISPD-NAC, member of ASN - Home Dialysis task force and HDU faculty allows addressing the workforce shortage at the national level and have an impact at the policy level. Dr. Bansal took over the role of program director (2017-2021) of a struggling nephrology fellowship, while the program was matching zero fellows. Establishing “change the status-quo in nephrology”, as the motto of the program, she revamped it by developing new curriculums, offering multiple tracks collaborating with other divisions, departments at the institute and private practice in the town, improving the education-service balance, and restructuring conferences organization etc. UT San Antonio Nephrology fellowship program has gained a national reputation and become a competitive clinical program through these efforts. Moreover, Dr. Bansal, co-founded and has been directing annual cardiorenal connections symposium, a conglomeration of all of her clinical, research and education efforts in cardiorenal area, since 2015 to bring together clinicians, nurses, dieticians, researchers, and industry to address the challenges in management of patients with concomitant heart, kidney and metabolic diseases. It has gained international recognition over the years.  

Dr. Bansal’s clinical and research interests focus on the volume/sodium control in the management of hypertension, CKD, dialysis and cardiorenal patients. She has received extra-mural and institutional grants and is the site-PI for important initiatives like TRIDENT consortium, NHLBI sponsored SPIRRIT-HF and several clinical industry grants. She has over 80 peer reviewed publications and chapters in high-impact journals such as Annals of Internal Medicine and JASN and has been regularly invited as faculty speaker at national and international conferences. She serves as the Associate Editor for Journal Clinical Nephrology, and editorial board member for several nephrology and cardiology journals.  She leads the Hub Liaison Team for Institutional Clinical and Translational Sciences Award. In this role, she has been active developing strategies to ensure efficient and timely conduct of clinical trials with effective recruitment at her Institute, dissemination and implementation of the TIN resources bidirectionally, and trialists workforce development, etc. She also served as the chair of the Institutional Review Board for 8 years.

Overall, Dr. Bansal strongly believes in academic medicine and its each domain – patient care, education, and research. She is humbled and privileged to have the current job that allows to have a meaningful impact on the lives of her patients through clinical care and research activities, and the lives of medical students, residents, and fellows through teaching.

 

  • Professional Background

    Education

    • 2009 - Certificate - Public Health - University of Colorado Health Sciences Center
    • 2009 - Postdoctoral Fellowship - Nephrology - University of Colorado Health Sciences Center
    • 2009 - Clinical Fellowship - Nephrology - University of Colorado Health Sciences Center
    • 2006 - Residency - Internal Medicine - University of Colorado Health Sciences Center
    • 2004 - Internship - Internal Medicine - University of Colorado Health Sciences Center
    • 2001 - Residency - Internal Medicine - Moulana Azad Medical College
    • 1998 - BM BS - Medicine - Swai Man Singh Medical College

    Highlights

    • 2023-2024: Outstanding Faculty in Senior Elective Education
    • 2011, 17 & 23: Award for Excellence in Teaching by Renal fellows
    • 2023: UT Presidential Award in the category of Clinical Excellence
    • 2022 & 23: Top Doctor by the peers in Nephrology, survey by SA Magazine
    • 2022: BCMS Extraordinary Women in Medicine Leadership Award
    • 2023: Outstanding Clerkship Educator
    • 2022: Women in Medicine by AMA
    • 2016: 1st prize in Junior Faculty category at Medicine Research Day

    Appointments

    • 11/2019 - Research Investigator WOC - South Texas Veterans Health Care System, Medicine, San Antonio
    • 3/2019 - Director, Nephrology Clinical Research Program - UT Health San Antonio, Medicine, San Antonio
    • 2/2018 - Program Director, Nephrology Fellowship - UT Health San Antonio, Medicine, San Antonio
    • 9/2016 - Associate Professor / Clinical and Associate Professor of Medicine (Nephrology) - UT Health San Antonio, Medicine, San Antonio
    • 11/2015 - Chair, Institutional Review Board-2 - UT Health San Antonio
    • 1/2011 - Medical Director - Home Dialysis Program - University Health System, Medicine, San Antonio
    • 09/2020 - Medical Director, CTSA- Hub Liaison Team - UT Health San Antonio

  • Instruction & Training

    • 5/2015 - Present, Family and Community Medicine, UTHSCSA
    • 11/2013 - Present, Pathophysiology for APN, The University of Texas Health Science Center
    • 10/2013 - Present, Medicine Resident Noon Conference, University of Texas Health Science Center at San Antonio
    • 5/2013 - Present, Medicine, Behavior Society, The University of Texas Health Science Center
    • 8/2012 - Present, Clinical Skills, The University of Texas Health Science Center
    • 2/2012 - Present, Medicine Clerkship, The University of Texas Health Science Center
    • 9/2011 - Present, Division of Nephrology: Monday Clinical Conference, University of Texas Health Science Center at San Antonio
    • 10/2010 - Present, Post Graduate Rotation Supervision, UTHSCSA

  • Research & Grants

    Grants

    1.  UM1 TR004538-01                                     Clark et al (multi-PI) 07/25/23 – 06/30/30

    “Institute for Integration of Medicine & Science: A Partnership to Improve Health”

    Major Goals: Clinical and Translational Science Award. This CTSA program provides a broad range of research infrastructure support across the institution and its CTSA partners.

    Role: Director, Hub Liaison Team (15% efforts).

    Total Award Amount (including Indirect Costs): $5,635,633/year.

     

    2. CTSA UL1TR002645                                   Debnath (PI) 07/2022-Current

    “Oral intradialytic amino acids supplementation to vitalize end-stage kidney patients on hemodialysis (OASIS)”

    Role: Sub-I (no efforts), Total cost $50,000

     

    3. University of Pennsylvania Sub award       Bansal (PI)     2017- till completion of study

    Transformative Research in Diabetic Nephropathy (TRIDENT)

    The goal of this project is to find the biomarkers for better diagnosis and treatment of diabetic nephropathy

    Type: Investigator initiated collaborative effort sponsored by Industry

    Role: Site-PI

     

    4. FIND-CKD. Bayer 21177-14010. Period 2021- till completion of the study

    “A randomized, double-blind, placebo-controlled, parallel-group, multicenter Phase 3 study to investigate the efficacy and safety of FInerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease”

    Type: Industry-sponsored study

    Role: Site PI

     

    5. ZEUS. Novonordisk EX6018-4758. Period 2021- till completion of the study

    “Effects of ziltivekimab versus placebo on cardiovascular outcomes in participants with established atherosclerotic cardiovascular disease, chronic kidney disease and systemic inflammation”

    Type: Industry-sponsored study

    Role: Site PI

     

    6. REDEFINE-3. NovoNordisk NN9838-4942. Period 2024 – till completion of the study

    Phase 3a CVOT assessing the cardiovascular safety and efficacy of cagrilintide 2.4 mg s.c. in combination with semaglutide 2.4 mg s.c. (CagriSema 2.4 mg/2.4 mg s.c.) once-weekly in participants with established cardiovascular disease (REDEFINE 3).

    Type: Industry-sponsored study

    Role: Site PI

     

    7. ZENITH. Astra Zeneca D4325C00010. Period 2024 – till completion of the study

    A Phase III, Randomised, Multicentre, Double-blind Study to Evaluate the Efficacy, Safety, and Tolerability of Zibotentan/Dapagliflozin Compared to Dapagliflozin Alone in Participants with Chronic Kidney Disease and High Proteinuria.

    Type: Industry-sponsored study

    Role: Site PI

  • Service

    School

    2015 - Current: Co-founder and Co-Director of Cardio Renal Metabolic Connections Meeting since 2015
    02/2018 – 06/2021: Program Director, Nephrology Fellowship
    11/2015- 08/2023: Chairperson, UTHSA IRB-2
    2018-Current: Veritas Mock Interview Night
    • I help MS4 prepare for their residency interviews via conducting mock interviews. I interview 2-4 applicants each year.
    2020-Current: Mock Interviews for the IM residents
    • Similar process for IM residents for fellowship interviews. I interview 2 residents each year.
    2012-Current: Interviews for the IM residents
    2022-Current: Clinical Trial Scholar Program
    • Speaker at the Clinical Trial Scholar Program sharing my 10+ years of participating in Industry sponsored clinical trials, stimulating participation from Junior investigators.
    Grant and Abstract Review
    • 2024 Grant Reviewer, Translational Science Training (TST) T32 Program
    • 2019 -Current Grant Reviewer for Claude D. Pepper Center Research Education Core
    • 2017-Current Judge, Medicine Research Day, UT Health San Antonio
    • 2015-2018 Grant Reviewer for Institute for Integration of Medicine and Science, UTHSCSA
    • 2015-2017 Grant reviewer for Diabetes complication consortium
    • 2015-Current Judge, Translational Science Annual Research Day, IIMS, UTHSCA
    2011-Current Member, Nephrology Program Evaluation Committee
    2011-Current Member, Nephrology Clinical Competence Committee

    Institutional

    November 2019 American Society of Nephrology (ASN) TV news
    April 2020 Texas Public Radio Panel discussant for SOURCE: COVID in diabetes and dialysis patients.
    June 2020 KENS5 TV coverage for COVID and Kidney Disease

    Community

    August 2018 Physician Volunteer - Free Health Fair, Indian Association of San Antonio
    April 2020 Physician volunteer for Heaven for Hope clinic

  • Publications

      Peer Reviewed Publications, last five years (Primary or corresponding author):

      1. Shweta Bansal, Kristina Munoz, Sonja Brune, Steve Bailey, Anand Prasad, and Chakradhar Velagapudi.  Recognizing and Treating Loop-Diuretic Resistant Acute Decompensated Heart Failure with High-dose Spironolactone. Annals of Internal Medicine. Online July 16, 2019. doi: 10.7326/M18-3285. PMID: 31307058
      2. Ricardo Rodriguez-Santos, Ashley Garcia-Everett, Raymond Kessler, Shweta Bansal. Rupture of peritoneal dialysis catheter without drainage failure. Clinical Nephrology. 2019 Dec;92(6):330-332. doi: 10.5414/CN109796. PMID: 31599228
      3. Bansal S, Kanakia R, Tsai S, Sharma K, Prasad A. Nephrology Training: Time to revisit integrative physiology. American Journal of Nephrology 2020; 51: 244–248. PMID 32062651
      4. Bansal S and Pergola P. Current management of hyperkalemia in patients on dialysis. Kidney International Reports 2020; 5: 779-789. PMID: 32518860
      5. Shweta Bansal, Michael Mader, and Jacqueline A. Pugh. Screening and Recognition of Chronic Kidney Disease in VA Health Care System Primary Care Clinics. Kidney360. September 2020, 1 (9): 904–915, 2020. doi: https://doi.org/10.34067/KID.0000532020
      6. Bansal, Shweta. People of South Asian Decent at High Risk for Cardiovascular Disease Shining light on the “Masala” Study. San Antonio Magazine. November 2022
      7. Akash Sharma, Rahul Patel, Anand Prasad and Shweta Bansal*. Diuretic resistance in acute decompensated HFpEF vs. HFrEF. Clinical Nephrology, 2023 Mar 27. doi: 10.5414/CN111090. Online ahead of print. PMID: 36970966
      8. Rahul Patel, Akash Sharma, Anand Prasad, and Shweta Bansal*. Heart Failure with Preserved Ejection Fraction: A Multispecialty Disorder. Kidney Medicine. 5(12):100705. Published online September 27, 2023. PMID: 38046909
      9. Shweta Bansal. Teamwork Makes Success Work. Interv Cardiol Clin . 2023 Oct;12(4):xi-xii. PMID: 37673502
      10. Vemireddy, L. & Bansal, S*. Contrast-Associated Acute Kidney Injury: Definitions, Epidemiology, Pathophysiology, and Implications. In:Interventional Cardiology Clinics. Oct 2023;12(4):489-498. PMID: 37673493
      11. Shweta Bansal, Maria E.F. Canziani, Rita Birne, Stefan D. Anker, George L. Bakris, Gerasimos Filippatos, Peter Rossing, Luis M. Ruilope, Alfredo E. Farjat, Peter Kolkhof, Andrea Lage, Meike Brinker and Bertram Pitt on behalf of the FIDELIO DKD and FIGARO-DKD investigators. Cardiorenal Outcomes by Age and Sex in Patients Treated with Finerenone: FIDELITY Post Hoc Analysis. BMJ Open, 2024;14:e076444. doi:10.1136/bmjopen-2023-076444
      12. Shweta Bansal, Robert Boucher, Jincheng Shen, Guo Wei, Glenn M. Chertow, Paul K. Whelton, William C. Cushman, Alfred K. Cheung, and Srinivasan Beddhu. The Role of Diuretics Use in Cardiovascular Events and All-cause Mortality in the Systolic Blood Pressure Intervention Trial (SPRINT): A post-hoc analysis. cJASN, 2024 Jan 23. doi: 10.2215/CJN.0000000000000406 PMID: 38262377
      13. Shweta Bansal. Invited review -Revisiting resistant hypertension in kidney disease. Current Opinion in Nephrology and Hypertension. Published online May 13, 2024. Curr Opin Nephrol Hypertens 2024, 33:465–473. PMID: 38726750
      14. Houry Puzantian, Raymond Townsend, Shweta Bansal. Obesity and Aldosterone Excess: Parallel or intersected circumstances? Journal of Hypertension. In press
      15. Shweta Bansal, Houry Puzantian, Raymond Townsend. Rising prevalence of obesity and primary hyperaldosteronism: Co-incidence or connected circumstances leading to hypertension? A Narrative Review. Journal of General Internal Medicine. In press
      16. Akwe Nyabera, Omar A Ayah, Gabriela Dande, Aadit Mehta4, Alexis Lorio, Shweta Bansal*. Peritoneal Dialysis in Patients with Severe Obesity: A Successful Single Center Experience. PDI- Undergoing second revision

      Peer Reviewed Publications, last five years (as a co-author):

      1. SONAR investigators, Hiddo J L Heerspink, Hans-Henrik Parving, Dennis L Andress, George Bakris, Ricardo Correa-Rotter, Fan-Fan Hou, Dalane W Kitzman, Donald Kohan, Hirofumi Makino, John J V McMurray, Joel Z Melnick, Michael G Miller, Pablo E Pergola, Vlado Perkovic, Sheldon Tobe, Tingting Yi, Melissa Wigderson, Dick de Zeeuw.  Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial. Lancet, published Online April 15, 2019, http://dx.doi.org/10.1016/S0140-6736(19)30772-X. Lancet. 2019 May 11;393(10184):1937-1947
      2. Ruben Rodriguez MD, Mohammed Hasoon MD, Marvin Eng MD, Joel Michalek PhD,  Qianqian Liu BS,  Brian Hernandez BS, Shweta Bansal MD,  Steven R Bailey MD, Anand Prasad MD. Incidence and Predictors of Acute Kidney Injury Following Transcatheter Aortic Valve Replacement: Role of Changing Definitions of Renal Function and Injury. Journal of Invasive Cardiology 2020 Jan 15. pii: JIC20200115-1. [Epub ahead of print]. PMID: 31941833
      3. Trident Study Investigators. Rationale and design of the Transformative Research in Diabetic Nephropathy (TRIDENT) Study. Kidney International. 2020 Jan;97(1),10–13. PMID: 31901339
      4. Jonathan J Hogan, Jonathan G Owen, Shira J Blady, Salem Almaani, Rupali S Avasare, Shweta Bansal, Oliver Lenz, Randy L Luciano, Samir V Parikh, Michael J Ross, Deep Sharma, Harold Szerlip, Shikha Wadhwani, Raymond R Townsend, Matthew B Palmer, Katalin Susztak, Amy K Mottl; TRIDENT Study Investigators. The Feasibility and Safety of Obtaining Research Kidney Biopsy Cores in Patients with Diabetes: an Interim Analysis of the TRIDENT Study. Clin J Am Soc Nephrol. 2020 Jul 1;15(7):1024-1026. doi: 10.2215/CJN.13061019. Epub 2020 Apr 27. PMID: 32341009
      5. Tung Nguyen, Omar Sheikh, Momhammed Shaar, Shweta Bansal, Anand Prasad. An Overview of Contrast Associated Acute Kidney Injury Following Lower Extremity Percutaneous Peripheral Interventions. The Journal of Invasive Cardiology. 2020 Jul;32(7):276-282. PMID: 32610269
      6. Subrata Debnath, Carlos Lorenzo, Shweta Bansal, Juan Morales, Rain O. Rueda, Balakuntalam S. Kasinath, Kumar Sharma, Jason C. O’Connor. Branched-chain amino acids depletion during hemodialysis is associated with fatigue. American Journal of Nephrology. 2020;51(7):565-571. doi: 10.1159/000507839. Epub 2020 Jun 23. PMID: 32575099
      7. Omar Sheikh, Tung Nguyen, Shweta Bansal, Anand Prasad. Acute Kidney Injury in Cardiogenic Shock: A Comprehensive Review. Catheterization and Cardiovascular Interventions. 2020 Jul 29. doi: 10.1002/ccd.29141. Online ahead of print. PMID: 32725874
      8. Subrata Debnath, Carlos Lorenzo, Rain Rueda, Shweta Bansal, Kumar Sharma. Assessment of fatigue in hemodialysis patients: performance of the Brief Fatigue Inventory. General Hospital Psychiatry. Online 17 August 2020. Jan 1 2021, 68, p. 115-117
      9. Pablo Michel, Javier Amione-Guerra, Omar Sheikh, Shweta Bansal, and Anand Prasad. Meta-analysis of Intravascular Volume Expansion Strategies to Prevent Acute Kidney Injury Following Invasive Angiography. Catheterization and Cardiovascular Interventions. Interventions. 13 November 2020
      10. Emilio D Poggio, Robyn L McClelland, Kristina N Blank, Spencer Hansen, Shweta Bansal, Andrew S Bomback, Pietro A Canetta, Pascale Khairallah, Krzysztof Kiryluk, Stewart H Lecker, Gearoid M McMahon, Paul M Palevsky, Samir Parikh, Sylvia E Rosas, Katherine Tuttle, Miguel A Vazquez, Anitha Vijayan, Brad H Rovin, Kidney Precision Medicine Project. Systematic Review and Meta-analysis of Native Kidney Biopsy Complications – A Collaborative Study for the Kidney Precision Medicine Project. Clin J Am Soc Nephrol. 2020 Nov 6;15(11):1595-1602. PMID 33060160
      11. FIDELIO-DKD Investigators. Bakris GL, Agarwal R, Anker SD, Pitt B, Ruilope LM, Rossing P, Kolkhof P, Nowack C, Schloemer P, Joseph A, Filippatos G. Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes. N Engl J Med. 2020 Dec 3;383(23):2219-2229. doi: 10.1056/NEJMoa2025845. Epub 2020 Oct 23. PMID: 33264825
      12. FIGARO-DKD Investigators. Pitt B, Filippatos G, Agarwal R, Anker SD, Bakris GL, Rossing P, Joseph A, Kolkhof P, Nowack C, Schloemer P, Ruilope LM; Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes. N Engl J Med. 2021 Dec 9;385(24):2252-2263. doi: 10.1056/NEJMoa2110956. Epub 2021 Aug 28. PMID: 34449181
      13. Kidney Precision Medicine Project Investigators. Rationale and design of the Kidney Precision Medicine Project. Mar 2021, In: Kidney international. 99, 3, p. 498-510 13 p.
      14. Kidney Precision Medicine Project Investigators. Patient perspectives and involvement in precision medicine research. Mar 2021, In: Kidney international. 99, 3, p. 511-514 4 p.
      15. TRIDENT Study Investigators. Abedini A, Zhu YO, Chatterjee S, Halasz G, Devalaraja-Narashimha K, Shrestha R, S Balzer M, Park J, Zhou T, Ma Z, Sullivan KM, Hu H, Sheng X, Liu H, Wei Y, Boustany-Kari CM, Patel U, Almaani S, Palmer M, Townsend R, Blady S, Hogan J, Morton L, Susztak K. Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney. J Am Soc Nephrol. 2021 Mar;32(3):614-627. doi: 10.1681/ASN.2020050757. Epub 2021 Feb 2. PMID: 33531352
      16. Tuttle, KR, Knight R, Appelbaum PS, Arora T, Bansal S, Bebiak J, Brown K, Campbell C, Cooperman L, Cronoa-Villalobos CP, Dighe A, de Boer IH, Hall DE, Jefferson N, Jolly S, Kermani, A Lee SC, Mehl K, Murugan R, Roberts GV, Rosas, SE, Himmelfarb J, Miller RT for the Kidney Precision Medicine Project. Integrating Patient Priorities with Science by Community Engagement in the Kidney Precision Medicine Project (KPMP). Clin J Am Soc Nephrol. 2021 Apr 7;16(4):660-668. PMID 33257411
      17. The SPRINT Research Group. Cora E. Lewis, Lawrence J. Fine, Srinivasan Beddhu, Alfred K. Cheung, William C. Cushman, Jeffrey A. Cutler, Gregory W. Evans, Karen C. Johnson, Dalane W. Kitzman, Suzanne Oparil, Mahboob Rahman, David M. Reboussin, Michael V. Rocco, Kaycee M. Sink, Joni K. Snyder, Paul K. Whelton, Jeff D. Williamson, Jackson T. Wright, Jr., and Walter T. Ambrosius. Final Report of a Trial of Intensive versus Standard Blood-Pressure Control. N Engl J Med 2021; 384:1921-30.
      18. Subrata Debnath, Carlos Lorenzo, Rain Rueda, Shweta Bansal, Balakuntalam S Kasinath, Kumar Sharma. Fatigue Dimensions on Dialysis and Non-dialysis Days in Maintenance Hemodialysis Patients. BMC Nephrology. Dec 2021, 22, 1, 112.
      19. Ilya M. Nasrallah, MD, PhD; Sarah A. Gaussoin, MS; Raymond Pomponio, BS; Sudipto Dolui, PhD; Guray Erus, PhD; Clinton B. Wright, MD, MS; Lenore J. Launer, PhD; John A. Detre, MD; David A. Wolk, MD; Christos Davatzikos, PhD; Jeff D. Williamson, MD; Nicholas M. Pajewski, PhD; R. Nick Bryan, MD, PhD; for the SPRINT Research Group. Association of Intensive vs Standard Blood Pressure Control with Magnetic Resonance Imaging Biomarkers of Alzheimer Disease. Secondary Analysis of the SPRINT MIND Randomized Trial. JAMA Neurol. 2021;78(5):568-577. doi:10.1001/jamaneurol.2021.0178
      20. Sankar D. Navaneethan, Carl P. Walther, L. Parker Gregg, Shweta Bansal, Wolfgang C. Winkelmayer, Vijay Nambi, Jingbo Niu. Mortality, Kidney Failure, and Hospitalization among Medicare Beneficiaries with CKD Diagnosed with Pulmonary Hypertension. AJKD, 2021 Apr 24; S0272- 6386 (21) 00570-9. PMID 33905766
      21. Insa M. Schmidt, Mia R. Colona, Bryan R. Kestenbaum, Leonidas G. Alexopoulos, Ragnar Palsson, Anand Srivastava, Jing Liu, Isaac E. Stillman, Helmut G. Rennke, Vishal S. Vaidya, Haojia Wu, Benjamin D. Humphreys, Sushrut S. Waikar, for the Kidney Precision Medicine Project. Cadherin-11, Sparc-related modular calcium binding protein-2, and Pigment epithelium derived factor are promising non-invasive biomarkers of kidney fibrosis. In: Kidney international. Sep 2021, 3, p. 672-683
      22. FIDELIO-DKD Investigators. Rossing P, Burgess E, Agarwal R, Anker SD, Filippatos G, Pitt B, Ruilope LM, Gillard P, MacIsaac RJ, Wainstein J, Joseph A, Brinker M, Roessig L, Scott C, Bakris GL Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes Care. 2022 Apr 1;45(4):888-897. doi: 10.2337/dc21-1944. PMID: 35061867
      23. Giuseppe Tarantini1, Anand Prasad, Sudhir Rathore, Shweta Bansal, Regine Gottfried, Alexander R. Rosenkranz, Carlo Briguori, Mohsen Yaghoubi, Atefeh Mashayekhi, Mehdi Javanbakht and Eoin Moloney. DyeVert Contrast Reduction System Use in Patients Undergoing Coronary and/or Peripheral Angiography: A Systematic Literature Review and Meta-Analysis. Front. Med., 2022 Apr 25;9:841876. PMID: 35547222
      24. Rajasree Menon, Andrew S. Bomback, Blue B. Lake, Christy Stutzke, Stephanie M. Grewenow, Steven Menez, Vivette D. D’Agati, Sanjay Jain, Kidney Precision Medicine Project. Integrated single-cell sequencing and histopathological analyses reveal diverse injury and repair responses in a participant with acute kidney injury: a clinical-molecular-pathologic correlation. In: Kidney international. Jun 2022, 6, p. 1116-1125
      25. Anand Prasad, Paul M. Palevsky, Shweta Bansal, Glenn Chertow, James Kaufman, Kianoush Kashani, Esther S.H. Kim, Lakshmi Sridharan, Amit P Amin, Sripal Bangalore, Carlo Briguori, David M. Charytan, Marvin Eng, Hani Jneid, Jeremiah R. Brown, Roxana Mehran, Mark J. Sarnak, Richard Solomon, Charuhas V. Thakar, Kevin Fowler, Steven Weisbord. Special Report. Management of Patients with Kidney Disease in need of Cardiovascular Catheterization: A Scientific Workshop Co-Sponsored by the National Kidney Foundation and the Society of Cardiovascular Angiography and Interventions. Journal of the Society for Cardiovascular Angiography & Interventions. Volume 1, Issue 6, November–December 2022, 100445
      26. Catherine R. Butler, Paul S. Appelbaum, Heather Ascani, Mark Aulisio, Catherine E. Campbell, Ian H. de Boer, Ashveena L. Dighe, Daniel E. Hall, Jonathan Himmelfarb, Richard Knight, Karla Mehl, Raghavan Murugan, Sylvia E. Rosas, John R. Sedor, John F. O’Toole, Katherine R. Tuttle, Sushrut S. Waikar, and Michael Freeman, for the Kidney Precision Medicine Project. A Participant-Centered Approach to Understanding Risks and Benefits of Participation in Research Informed by the Kidney Precision Medicine Project. Am J Kidney Dis . 2022 Jul;80(1):132-138. PMID: 34871700
      27. FIDELIO-DKD and FIGARO-DKD Investigators. Rossing P, Anker SD, Filippatos G, Pitt B, Ruilope LM, Birkenfeld AL, McGill JB, Rosas SE, Joseph A, Gebel M, Roberts L, Scheerer MF, Bakris GL, Agarwal R. Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium-Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis. Diabetes Care. 2022 Dec 1;45(12):2991-2998. doi: 10.2337/dc22-0294. PMID: 35972218
      28. The EMPA-KIDNEY Collaborative Group. Empagliflozin in Patients with Chronic Kidney Disease. N Engl J Med. 2023 Jan 12;388(2):117-127. PMID 36331190
      29. Yuvaram N.V. Reddy, Jeffrey S. Berns, Shweta Bansal, James F. Simon, Ryan Murray, Molly Jacob, Jeffrey Perl, Edward Gould. Home Dialysis Training Needs for Fellows: A Survey of Nephrology Program Directors and Division Chiefs in the United States. Kidney Medicine, 2023 Mar 20;5(5):100629. doi:10.1016/j.xkme.2023.100629. eCollection 2023 May. PMID: 37229444
      30. Farah AbiFaraj, Dale Lee, Meghan Lacovara, Tarun Kapoor, Rebecca Seshasai, Shweta Bansal, Robert Greevy, Andrew Guide, Shuchita Sharma, Jaime Uribarri, Osama El Shamy. A Survey of Peritoneal Dialysis Patients’ Challenges and Experiences during the COVID-19 pandemic: A multi-center study in the United States. Kidney360, 2023 Jun 26. PMID: 37357350
      31. MA Sahlawi, B Bieber, S Bansal, G Block, T Masud, B Piraino, M Schreiber, V Srivatana, I Teitelbaum, S Khan, OE Shamy, S Watnick, L Garcia, RL Pisoni, J Perl. Standardized Peritonitis Reporting: A Quality Improvement Initiative of The Optimizing the Prevention of Peritoneal Dialysis Associated Peritonitis in the United States (OPPUS) Study. AJKD, 2023 Oct 24: S0272-6386(23)00885-5. doi: 10.1053/j.ajkd.2023.09.004. PMID: 37879528
      32. Marisha E. Palm, Dixie D. Thompson, Terri Edwards, Kitt Swartz, Keith A. Herzog, Shweta Bansal, Benjamin Echalier, Kristen Clasen DeHart, Signe Denmark, Jurran L. Wilson, Sarah Nelson, Salina P. Waddy, Sarah E. Dunsmore, Jane C. Atkinson, Jamie P. Dwyer, Daniel F. Hanley, J. Michael Dean, Daniel E. Ford. The Trial Innovation Network Liaison Team: Building a National Clinical and Translational Community of Practice. Journal of Clinical and Translational Science, 2023 Nov 6;7(1): e249. doi: 10.1017/cts.2023.675 PMID: 38229890
      33. FIDELIO-DKD and FIGARO-DKD Investigators. Agarwal R, Tu W, Farjat AE, Farag YMK, Toto R, Kaul S, Lawatscheck R, Rohwedder K, Ruilope LM, Rossing P, Pitt B, Filippatos G, Anker SD, Bakris GL. Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis. Ann Intern Med. 2023 Dec;176(12):1606-1616. doi: 10.7326/M23-1023. Epub 2023 Dec 5. PMID: 38048573
      34. FLOW Investigators. Vlado Perkovic, Katherine R. Tuttle, Peter Rossing, Kenneth W. Mahaffey, Johannes F.E. Mann, George Bakris, Florian M.M. Baeres, Thomas Idorn, Heidrun Bosch-Traberg, Nanna Leonora Lausvig, and Richard Pratley. Effects of Semaglutide on Chronic Kidney Disease in Patients with Type 2 Diabetes. NEJM. Published May 24, 2024. DOI: 10.1056/NEJMoa2403347
      35. Devika Aggarwal; Rebecca Young; Milan Seth; Daniel M Wojdyla; Devraj Sukul; Tracy Y Wang; Simon R Dixon; Michael R Rudnick; Shweta Bansal; Carlo Briguori; Hitinder S. Gurm. Contemporary Contrast Media Dosing During Percutaneous Coronary Intervention in Patients with Pre-existing Renal Impairment in the United States. The European Journal of Heart Failure. Submitted
      36. Samer Mohandes, Amy Mottl, Julia Sciala, Salem Almaani, Randy Luciano, Tamara Isakova, Shweta Bansal, Christos Argyropoulos, Jonathan Hogan, Gaia Coppock, Raymond Townsend, TRIDENT Cohort, Katalin Susztak*, Matthew Palmer. Improving the histological classification of diabetic nephropathy based on the Transformative Research in Diabetic Nephropathy (TRIDENT) results. Manuscript submitted KI

  • Clinical

    Board Certifications

    • American Board of Internal Medicine/Nephrology